期刊文献+

人肿瘤浸润γδΤ细胞的抗肿瘤活性研究 被引量:7

Study on antitumor activity of expanded human infiltrating gamma-delta T lymphocytes
下载PDF
导出
摘要 目的研究人直肠癌和结肠癌的肿瘤浸润 γδT淋巴细胞 ( γδTIL s)体外抗肿瘤活性。方法用固相抗体法体外扩增获得γδTIL s,并用 MTT法和 3H- Td R掺入实验体外观察γδTIL s对同种异体和异种肿瘤细胞的细胞毒及增殖反应。结果所获得γδTIL s对所测定的肿瘤细胞显示出明显的细胞毒活性。该杀伤效应可为 IL - 2 ,IL - 4,IL - 12 ,IL - 15 ,TNF-α和 IFN -γ所增强 ,而不受 IL - 10 ,GM- CSF和 TGF-β所影响。某些去增殖活性的肿瘤细胞可诱导静息化的γδTIL s产生显著的增殖反应。结论 γδTIL Objective To investigate the antitumor activity of selectively expanded human colorectal γδ tumorinfiltrating T lymphocytes(TILs)in vitro.Methods γδTILs were expanded by solid phaseantibody method,whose cytolytic and proliferative activities were detected by MTT method and 3HTdR incorporation.Results Expanded γδTILs demonstrated marked cytotoxicites to allogeneic and isogeneic tumor cell lines.Cytokines including IL2,IL4,IL12,IL15,TNFα and INFγ could promote the cytotoxicities of γδTILs,while IL10,GMCSF and TGFβ had no effect on such killing activities.Rested γδTILs could proliferate in response to some mitomycin Ctreated tumor cells.Conclusions γδTILs could play an important role in antitumor response via their cytotoxicity to tumor cells. [
出处 《免疫学杂志》 CAS CSCD 北大核心 2000年第3期175-178,共4页 Immunological Journal
基金 国家重点基础研究发展规划!(G1998051200)中子课题 (G1998051214) 国家自然科学基金!(39670373)资助项目
关键词 肿瘤浸润 ΓΔT细胞 细胞毒 结直肠肿瘤 tumor tumor infiltrating lymphocytes γδT cells cytotoxicity cytokine
  • 相关文献

参考文献1

二级参考文献4

  • 1于松涛,国外医学免疫学分册,1997年,20卷,2期,57页
  • 2何维,中国免疫学杂志,1995年,11卷,增刊,77页
  • 3王文阁,实用肿瘤学杂志,1993年,4期,13页
  • 4何维,巴德年.γδT细胞的生物学意义[J].上海免疫学杂志,1997,17(1):1-3. 被引量:10

共引文献13

同被引文献92

  • 1戴梦华,何维,赵玉沛,许春萍.外周血γδT细胞在胰腺癌裸鼠过继免疫治疗中的作用[J].中华外科杂志,2005,43(11):726-729. 被引量:3
  • 2华锦明,郑祖根,徐庚达.骨转移瘤肿瘤浸润淋巴细胞过继免疫治疗的临床研究[J].中华肿瘤杂志,1994,16(3):203-206. 被引量:7
  • 3李新燕,张学光,张毅,李明,M.M.Hallet,B.Klein.特异性体外扩增人γδT淋巴细胞及其生物学特性的研究[J].中华医学杂志,1997,77(2):111-114. 被引量:9
  • 4杨贵贞.医学免疫学(第4版)[M].吉林科学技术出版社,1998.40-42.
  • 5[1]Rosenberg SA, Spies PS, Lafreniere R, et al. A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphcytes. Science,1986,233:1318 - 1321.
  • 6[2]Kradian RL, Botle LA, Preffer FI, et al. Tumor derived interlekin 2 dependent lymphocytes inadoptive immunotherapy of lung cancer Cancer Immunol I mmunother, 1987,24: 76 - 91.
  • 7[3]Toplian SL, Solomon D, Avis FP, et al. Immunotherapy of patients with advanced cancer using tumor infiltrating lymphocytesand recombinant interleukin 2: a pilot study. J Clin Oncol, 1988, 6: 839 - 845.
  • 8[5]Franklin R, Figlin R, Rauch J, et al. Cytoreductive surgery in the manegement of metastatic renal cell carcinoma: the UCLA experience. Semin Urol, 1996,14: 230 - 236.
  • 9[7]Zeng G. MHC Class Restricted Tumor Antigens Recognized by CD4( + )T cells: New strategies for cancer Vaccine Design. J Immunother, 2001,24:195 - 204.
  • 10[8]Ridolfi K, Flamini R, Ricobom A, et al. Adjunant adoptive immunotherapy with tumor infiltrating lymphocytes and modulated does of intedeukin 2 in patients with melanoma colorectal and renal cancer, after radical metastasectomy and in advanced patients. CancerImmunol Immunother, 1998,46:185- 193.

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部